SELLAS Life Sciences Group Inc
(FRA:RXK3)
€
1.056
-0.008 (-0.75%)
Market Cap: 66.08 Mil
Enterprise Value: 49.63 Mil
PE Ratio: 0
PB Ratio: 7.12
GF Score: 36/100 SELLAS Life Sciences Group Inc (FRA:RXK3) Transcripts
- Sellas Life Sciences Group Inc Corporate Update Call TranscriptJan 03, 2024
- Sellas Life Sciences Group Inc Expert Panel Discussion TranscriptMay 30, 2023
- Sellas Life Sciences Group Inc to Host Key Opinion Leader Webinar TranscriptJan 31, 2023
- Sellas Life Sciences Group Inc Galinpepimut-S Update Call TranscriptNov 14, 2022
- Sellas Life Sciences Group Inc Galinpepimut-S Update Call TranscriptSep 15, 2022
- Sellas Life Sciences Group Inc Provides Business Update and First Quarter 2022 Highlights TranscriptApr 06, 2022
- Sellas Life Sciences Group Inc Virtual Investor Symposium Corporate Call TranscriptAug 17, 2021
- Sellas Life Sciences Group Inc Shareholder Update Call TranscriptJun 03, 2021
- Sellas Life Sciences Group Inc Annual Shareholders Meeting TranscriptJun 09, 2020
- Sellas Life Sciences Group Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- Sellas Life Sciences Group Inc Corporate Analyst Meeting TranscriptNov 15, 2019
- 1